RECALL RECORD — CLASS IIRecall closedF-0860-2021/FDA enforcement
Monfefo LLC·Food·Jul 26, 2021

Monfefo Brand Turmeric Shot

What you need to know

Class II
  • What happened

    Product was not manufactured according to specifications.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDANY, NJ, CT, TX +15 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameMonfefo LLC
Recalling firmMonfefo LLCBrooklyn, NY, United States
UPC / barcodes
6 60002 51544 18 60002 51541 0
Lot / date codes
  • Turmeric Shot 12 pack: UPC 660002515441 Turmeric Shot single shot: UPC 860002515410 LOTS: 1942128
  • 1882127
  • 1792126 EXP: 8/17/21
  • 8/23/21
  • 9/14/21
  • 9/21/21
Distribution area
NYNJCTTXMDDCFLMEMAVTOHPAVAGANCSCWICOCA

NY, NJ, CT, TX, MD, DC, FL, ME, MA, VT, OH, PA, VA, GA, NC, SC, WI, CO, CA

United States

Quantity affected25 cases
Recall initiationFDA report date: August 18, 2021
FDA recall numberF-0860-2021

Beyond the headline

The recall, in context

Monfefo LLC initiated this food recall on July 26, 2021. The FDA enforcement report states: Product was not manufactured according to specifications. The FDA report lists distribution as: NY, NJ, CT, TX, MD, DC, FL, ME, MA, VT, OH, PA, VA, GA, NC, SC, WI, CO, CA.

The FDA enforcement report describes the reason as: Product was not manufactured according to specifications.

Monfefo Brand Turmeric Shot was made or distributed by Monfefo LLC in Brooklyn, NY, United States. This page reflects FDA report F-0860-2021, dated August 18, 2021.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Product safety recall

Symptoms to watch for

The official enforcement report describes the specific risk. Follow the recall notice, check the product codes and do not use a product that may be affected.

Higher-risk groups

Children, pregnant people, older adults and people with weakened immune systems should take extra care when a product's safety is uncertain.

What to do now

  1. 1Stop using or eating the product and keep it away from children and pets.
  2. 2Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return.
  3. 3Seek medical advice if anyone develops severe or worrying symptoms after exposure.

Read the official source record for the specific hazard and instructions.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Monfefo Brand Turmeric Shot recall?

Monfefo LLC recalled Monfefo Brand Turmeric Shot in an FDA Class II enforcement action reported as F-0860-2021. Product was not manufactured according to specifications.

What are the symptoms of Product safety recall exposure?

The official enforcement report describes the specific risk. Follow the recall notice, check the product codes and do not use a product that may be affected.

Who is most at risk from Product safety recall?

Children, pregnant people, older adults and people with weakened immune systems should take extra care when a product's safety is uncertain.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Stop using or eating the product and keep it away from children and pets. Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return. Seek medical advice if anyone develops severe or worrying symptoms after exposure.

How do I get a refund from Monfefo LLC?

Contact the recalling company or the retailer where you purchased the product, quote the FDA recall number and ask about a refund or replacement. Keep the packaging, lot code and proof of purchase where possible. The FDA does not issue consumer refunds. Reference FDA recall F-0860-2021 and keep the packaging, lot code and proof of purchase if you have them.

Is the Monfefo LLC recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0860-2021. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Related alerts

Recent Other safety concern recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.